These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 19769)

  • 21. The levels of methadone in the plasma in methadone maintenance.
    Inturrisi CE; Verebely K
    Clin Pharmacol Ther; 1972; 13(5):633-7. PubMed ID: 5053808
    [No Abstract]   [Full Text] [Related]  

  • 22. Methadone disposition in patients with chronic liver disease.
    Novick DM; Kreek MJ; Fanizza AM; Yancovitz SR; Gelb AM; Stenger RJ
    Clin Pharmacol Ther; 1981 Sep; 30(3):353-62. PubMed ID: 7273599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. State-trait anxiety in methadone maintenance patients.
    Teichman M
    Int J Addict; 1981 Aug; 16(6):1125-8. PubMed ID: 7341506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Criteria for judging methadone maintenance programs.
    Newman RG; Des Jarlais DC
    JAMA; 1991 May; 265(17):2190-1. PubMed ID: 2013946
    [No Abstract]   [Full Text] [Related]  

  • 25. Ineffective use of psychoactive drugs. Methadone treatment is no exception.
    Cooper JR
    JAMA; 1992 Jan; 267(2):281-2. PubMed ID: 1727529
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug clinics today.
    Hewitt L
    Lancet; 1983 Apr; 1(8331):990. PubMed ID: 6132297
    [No Abstract]   [Full Text] [Related]  

  • 27. N-oxidation--an important route in the metabolism of methadone in man.
    Beckett AH; Vaughan DP; Essien EE
    J Pharm Pharmacol; 1972 Mar; 24(3):244. PubMed ID: 4402786
    [No Abstract]   [Full Text] [Related]  

  • 28. Methadone: evidence of accumulation.
    Leslie ST; Miller RB; Boroda C
    Br Med J; 1977 May; 1(6071):1284. PubMed ID: 861579
    [No Abstract]   [Full Text] [Related]  

  • 29. Methadone maintenance: effect of urinary pH on renal clearance in chronic high and low doses.
    Bellward GD; Warren PM; Howald W; Axelson JE; Abbott FS
    Clin Pharmacol Ther; 1977 Jul; 22(1):92-9. PubMed ID: 17500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered dose incentive procedures: effects on polydrug use among methadone maintenance patients.
    Stitzer ML; Bickel WK; Bigelow GE
    NIDA Res Monogr; 1987; 76():162-7. PubMed ID: 3125444
    [No Abstract]   [Full Text] [Related]  

  • 31. Methadone dosage and retention of patients in maintenance treatment.
    Caplehorn JR; Bell J
    Med J Aust; 1991 Feb; 154(3):195-9. PubMed ID: 1988793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of methadone in methadone maintenance treatment: characterization of therapeutic failures.
    Nilsson MI; Grönbladh L; Widerlöv E; Anggård E
    Eur J Clin Pharmacol; 1983; 25(4):497-501. PubMed ID: 6653644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steady-state pharmacokinetics of methadone maintenance patients: renal clearance in low vs high dosages.
    Bellward GD
    Proc West Pharmacol Soc; 1977; 20():483-5. PubMed ID: 19769
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.